About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lupus Clinical Trials in New York | 26 Studies

Clinical Trials LupusNew York

Lupus Clinical Trials in New York

Find 26 clinical trials for lupus near New York, New York. Connect with research centers in your area.

All Lupus trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 26 trials

CompletedJBT-101 in Systemic Lupus Erythematosus (SLE)The objective of this study is to evaluate the efficacy, safety, and tolerability of JBT-101 (also known as lenabasum) in systemic lupus erythematosus (SLE).NCT03093402·La Jolla, California and 15 others CompletedA Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus ErythematosusThis is a Phase II/III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of rituximab compared with placebo when combined with a…NCT00137969·Birmingham, Alabama and 64 others

Lupus Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingA Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune DiseaseThis is a first-in-human, single-arm, open-label study evaluating the safety, tolerability, and preliminary efficacy of ALLO-329 in adults with autoimmune diseases: systemic lupus…NCT07085104·Phoenix, Arizona and 17 others

TerminatedA Study of Ustekinumab in Participants With Active Systemic Lupus ErythematosusThe purpose of this study is to evaluate the efficacy of ustekinumab in participants with active systemic lupus erythematosus (SLE) who have not adequately responded to one or…NCT03517722·Anniston, Alabama and 203 others

TerminatedEfficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus ErythematosusThe primary objective is to evaluate the efficacy and safety of efavaleukin alfa in subjects with active systemic lupus erythematosus.NCT04680637·Birmingham, Alabama and 149 others

TerminatedRandomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)This trial seeks to describe the effect of withdrawal from mycophenolate mofetil (MMF) on risk of clinically significant disease reactivation in quiescent SLE patients who have…NCT01946880·Los Angeles, California and 18 others

RecruitingA Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132The purpose of this study is to allow the continued administration of Deucravacitinib in participants with Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous…NCT06875960·Farmington, Connecticut and 3 others

UnknownThe Systemic Lupus Erythematosus (SLE) Activity Gene Expression (SAGE) StudyThe goal of this study is to enable the study sponsor to develop a new blood test method for clinicians to accurately predict which individuals with lupus will flare, when the…NCT00671047·Los Angeles, California and 11 others

CompletedPreventive IVIG Therapy for Congenital Heart BlockNeonatal lupus (NL) is the name given to a group of conditions that can affect the babies of mothers who have certain autoantibodies against components of the body's cells that…NCT00460928·Livingston, New Jersey and 1 other

RecruitingObe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)The purpose of this trial is to evaluate the efficacy and safety of obecabtagene autoleucel (obe-cel) administered once following lymphodepletion in participants with severe…NCT07053800·New York, New York and 15 others

RecruitingEffects of Stopping Hydroxychloroquine in Elderly Lupus DiseaseHydroxychloroquine (HCQ) is a systemic lupus erythematosus (SLE) medication that has been very effective in reducing lupus disease activity and keeping patients stable with…NCT05799378·Los Angeles, California and 11 others

CompletedDexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With LupusSome newborns are born with congenital heart block (CHB), a condition occurring in babies with neonatal lupus.NCT00007358·New Haven, Connecticut and 3 others

TerminatedNelfinavir in Systemic Lupus ErythematosusSystemic Lupus Erythematosus (SLE) is a chronic autoimmune disease in which the body's immune system attacks different parts of the body.NCT02066311·Los Angeles, California and 7 others

CompletedPreventive Approach to Congenital Heart Block With HydroxychloroquineWomen with antibodies to proteins called SSA/Ro and or SSB/La face a 2% chance of having a child with a life threatening heart condition regardless of whether they have very…NCT01379573·New York, New York

CompletedTriptorelin for Ovary Protection in Childhood Onset LupusThe purpose of this study is to test the safety of triptorelin when used for the protection of the ovaries (pair of female reproductive organs) during cyclophosphamide therapy for…NCT00124514·Los Angeles, California and 9 others

TerminatedAtorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus ErythematosusThis study uses the cholesterol lowering drug atorvastatin, also known as lipitor, to show reduction of avascular necrosis in steroid treated lupus patients.NCT00412841·New York, New York

CompletedEfficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusThe purpose of the study is to assess the efficacy and safety of 4 doses of cenerimod versus placebo in adult subjects with systemic lupus erythematosus (SLE).NCT03742037·Anniston, Alabama and 147 others

Active not recruitingCentrally Acting ACE Inhibition in SLESLE is a chronic autoimmune disease that often involves multiple systems and organs of the body.NCT04486118·New Haven, Connecticut and 6 others

CompletedA Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus ErythematosusThis is a study to evaluate the safety and efficacy of GDC-0853 in combination with standard of care therapy in participants with moderate to severe active systemic lupus…NCT02908100·Birmingham, Alabama and 69 others

CompletedEfficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)The purpose of this study is to determine if Rozibafusp Alfa could be a useful therapeutic agent in the current treatment landscape where subjects with SLE have ongoing disease…NCT04058028·Birmingham, Alabama and 146 others

Page 1 of 2Next

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia